These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14804286)

  • 1. Relative experimental coronary vasodilator potencies of papaverine and its ethyl analogue, ethaverine (diquinol, perparin).
    WINDER CV; THOMAS RW; KAMM O
    J Pharmacol Exp Ther; 1950 Dec; 100(4:1):482-8. PubMed ID: 14804286
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative experimental coronary vasodilator potencies and toxicities of papaverine, theophylline, and a papaverine-theophylline molecular association compound.
    WINDER CV; KAISER ME
    J Pharmacol Exp Ther; 1948 May; 93(1):86-92. PubMed ID: 18865189
    [No Abstract]   [Full Text] [Related]  

  • 3. [PHARMACOLOGY OF CORONARY VASODILATOR AGENTS].
    HASHIMOTO T
    Sogo Rinsho; 1964 Mar; 13():445-51. PubMed ID: 14140831
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of some coronary vasodilator drugs on collateral hemodynamics after chronic myocardial ischemia in the anesthetized dog: appropriate or inappropriate redistribution?
    Lacroix P; Linee P; Le Polles JB
    J Pharmacol Exp Ther; 1978 Mar; 204(3):645-54. PubMed ID: 633070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the effect of ethaverine and papaverine on post-ischemic arrhythmias in the awake dog].
    Lacroix P; Linée P; Le Pollés JB
    C R Seances Soc Biol Fil; 1977; 171(5):1075-80. PubMed ID: 146549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [INVERSION OF THE CORONARY DILATOR EFFECT OF SOME DRUGS BY ERGOTAMINE TARTRATE].
    ESPLUGUES J; BRUGGER A; HUESO E; SOTO L
    Rev Esp Fisiol; 1963 Dec; 19():155-62. PubMed ID: 14165287
    [No Abstract]   [Full Text] [Related]  

  • 7. Papaverine analogs. VI. Relationship between chemical structure and coronary vasodilator action.
    HANNA C; SHUTT JH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 220(1-2):43-51. PubMed ID: 13132927
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of action of papaverine on isolated coronary vessels].
    Kukovetz WR; Juan H; Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):262-3. PubMed ID: 4310612
    [No Abstract]   [Full Text] [Related]  

  • 10. CORONARY vasodilators.
    Mod Hosp; 1953 Feb; 80(2):114-8. PubMed ID: 13025304
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the biological evaluation of coronary dilator agents].
    KHADZHAI IaI; CHERKASOVA IN
    Farmakol Toksikol; 1962; 25():573-8. PubMed ID: 14032230
    [No Abstract]   [Full Text] [Related]  

  • 12. [Symposium--coronary hemodynamic response to autonomic drugs and coronary vasodilators. 4. Coronary vasodilation produced by prostaglandin El (PGE1), dipyridamole, MG-345, acetylcholine, papaverine and sodium nitrite in the dog].
    Abiko Y; Minamidate A
    Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):95. PubMed ID: 5531435
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative activity of ethaverine and papaverine on chronotropic and dromotropic cardiac functions in the anesthetized dog].
    Lacroix P; Linee P; Quiniou P; Polles JP
    Arch Int Pharmacodyn Ther; 1976 May; 221(1):163-76. PubMed ID: 962426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative effect of dihydrosamidine, pterixin and papaverine on the vessels in cholesterol-induced atherosclerosis of rabbits].
    Sharova GP
    Farmakol Toksikol; 1968; 31(3):284-7. PubMed ID: 5698107
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracoronary papaverine induced myocardial lactate production in patients with angiographically normal coronary arteries.
    Takeuchi M; Nohtomi Y; Kuroiwa A
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):126-30. PubMed ID: 8922310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of coronary vasodilator on cyclic nucleotides. The concentrations of cyclic AMP and cyclic GMP in canine coronary artery and left ventricular muscle following the administration of various coronary vasodilators.
    Kobayashi A; Ogawa K
    Jpn Circ J; 1979 Dec; 43 Suppl 1():6-8, 46-54. PubMed ID: 230369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phosphodiesterase inhibition as the action mechanism of various coronary vasodilator agents].
    Kukovetz WR; Pöch G; Holzmann S
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):730. PubMed ID: 4341664
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effects of coronary vasodilator papaverine on heterologously-expressed HERG currents in Xenopus oocytes.
    Kim CS; Lee N; Son SJ; Lee KS; Kim HS; Kwak YG; Chae SW; Lee SD; Jeon BH; Park JB
    Acta Pharmacol Sin; 2007 Apr; 28(4):503-10. PubMed ID: 17376289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of euphyllin, papaverine, nitroglycerin and chloracizin on coronary vessel tone and myocardial oxygen consumption under isolated heart conditions (Langendorf's method)].
    Buianov VV; Kisin IE
    Vestn Akad Med Nauk SSSR; 1963; 18(1):36-41. PubMed ID: 4971963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.